|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2014
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/19350
Title: | Particularities of validation HPLC method dosing |
Authors: | Muntean, Marina Vîslouh, Oxana |
Keywords: | HPLC;accuracy;detection limit;linearity;precision;range;recovery;robustness;stability;specificity |
Issue Date: | 2014 |
Publisher: | Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association |
Citation: | Muntean Marina, Vîslouh Oxana. Particularities of validation HPLC method dosing. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 243. |
Abstract: | Introduction: Chromatographic methods are commonly used for the quantitative and
qualitative analysis of raw materials, drug substances, drug products and compounds in biological
fluids. Validation of a method is the process by which a method is tested by the developer or user for
reliability, accuracy and preciseness of its intended purpose.
Materials and methods: Advanced bibliographic study.
Results: Though many types of HPLC techniques are available; the most commonly
submitted method, the reversed-phase HPLC with UV detection, is selected to illustrate the
parameters for validation. A. Accuracy is the measure of how close the experimental value is to the
true value. Accuracy studies for drug substance and drug product are recommended to be performed
at 80-100 and 120% levels of label claim as stated in the Guideline for Submitting Samples and
Analytical Data for Methods Validation. B. Limit of Detection and Limit of Quantitation
specifications are submitted with the regulatory impurities method relating to release and stability
of both drug substance and drug product. C. Linearity range of detectability that obeys Beer's Law
is dependent on the compound analyzed and detector used. D. Precision is the measure, that
expresses the closeness of data values between a series of measurements obtained under unchanged
analytical conditions. E. Range is the interval between the upper and lower levels of analyte studied.
F. Recovery is defined as the observed result obtained from an amount of the analyts compared to
the expected result obtained from theoretical amount and expressed as a percentage. G. Robustness
is defined by ICH as a measure of the method's capability to remain unaffected by small, but
deliberate variations in method parameters. H. Sample Solution Stability of the drug substance or
drug product after preparation according to the test method should be evaluated according to the test
method.I. Specificity/selectivity: the analyte should have no interference from other extraneous
components and be well resolved from them. J. System Suitability Specifications and Tests are
parameters that provide assistance in achieving this purpose.
These parameters will be used to validate the method of assay of cinnamic acid from Tolu
Balm in tablets.
Conclusions: The variations due to the drug product manufacturing process, the laboratory
sample preparation procedure and the performance instrument contribute to the accuracy of the data
obtained from the analysis. Only with good reliable validated methods, data, generated for release,
stability, and pharmacokinetics, can be trust-worthy. |
metadata.dc.relation.ispartof: | MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova |
URI: | http://repository.usmf.md/handle/20.500.12710/19350 |
Appears in Collections: | MedEspera 2014
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|